Cross-Linking Antisense Oligodeoxyribonucleotides with a Photoresponsive α-Chloroaldehyde Moiety for RNA Point

Yuta Sugihara1, Yuki Nakata1, Asako Yamayoshi2,3

  • 1Department of Biomolecular Engineering, Graduate School of Science and Technology, Kyoto Institute of Technology , Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.

Insights

Researchers developed novel photo-cross-linking oligodeoxyribonucleotides ((pro)PCA-ODNs) for targeted RNA mutation detection. These reagents efficiently and selectively bind to specific RNA sequences, offering potential for new anticancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oligonucleotide Therapeutics

Background:

  • Point mutations in GTPase-coding genes are implicated in cellular transformation.
  • Development of targeted anticancer reagents for specific RNA mutations is crucial.
  • Need for sequence-selective agents that can identify and react with mutated RNA.

Purpose of the Study:

  • To develop novel photo-cross-linking oligodeoxyribonucleotides ((pro)PCA-ODNs).
  • To investigate the reactivity and selectivity of these ODNs with target RNAs.
  • To assess the potential of (pro)PCA-ODNs as anticancer reagents.

Main Methods:

  • Synthesis of (pro)PCA-ODNs with a caged α-chloroaldehyde group on a 2-methylpropanediyl backbone.
  • Kinetic study to determine the deprotection rate of the caged group.
  • Photo-cross-linking experiments with complementary oligoribonucleotides (ORNs).

Main Results:

  • The bis(2-nitrobenzyl)acetal group in (pro)PCA-ODNs showed complete deprotection within 1 minute.
  • (pro)PCA-ODNs demonstrated efficient and sequence-selective photo-cross-linking with target ORNs.
  • Reactivity was observed with ORNs containing adenosine or cytidine at the position adjacent to the mutation site, without affecting nearby bases.

Conclusions:

  • Novel (pro)PCA-ODNs are effective photo-cross-linking agents for targeting specific RNA mutations.
  • These ODNs exhibit high selectivity and efficiency in reacting with mutated RNA sequences.
  • The developed technology shows promise for the development of sequence-selective anticancer reagents.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.6K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.2K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
36.2K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.3K